Medication info
Tijipri Tablets (Fenofibrate)

Tijipri Tablets (Fenofibrate)

Prescription medicationTabletOral
Ingredient · strength
Fenofibrate›160mg / 1 tablet
Manufacturer / importer
Yu Yeong Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
100 tablets (10 tablets/PTP packaging x 10)
Approval status
Active

MFDS item code 201303045 · Approved 2013.01.31 · Insurance code 648203600

Summary

Main use
Treatment of primary hyperlipidemia (e.g., hypertriglyceridemia and hypercholesterolemia)
Who takes it
Adults · Children
Adult dose
Fenofibrate must be administered in conjunction with dietary therapy. Because this medicine may be less well absorbed on an empty stomach, take it immediately after a meal. ○ Adults: Take 160 mg of fenofibrate orally once daily, immediately after a meal. ○ Older adults: Dose reduction is generally not necessary if renal function is not impaired. ○ Patients with renal impairment: Do not administer this medicine to patients with moderate to severe renal impairment (serum creatinine level of 2.5 mg/dL or greater).
Child dose
○ Children: Clinical data on the use of this medicine in children are not yet available.

Ingredients

Manufacturer
Yu Yeong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of primary hyperlipidemia (e.g., hypertriglyceridemia and hypercholesterolemia)

  • Primary hyperlipidemia
  • hypercholesterolemia
  • hypertriglyceridemia
View approved original text

This medication is used for typical diseases such as primary hyperlipidemia including hypercholesterolemia (Type IIa), combined hypercholesterolemia and hypertriglyceridemia (Type IIb, III), and hypertriglyceridemia (Type IV).

How to take

Adult dose

Fenofibrate must be administered in conjunction with dietary therapy. Because this medicine may be less well absorbed on an empty stomach, take it immediately after a meal. ○ Adults: Take 160 mg of fenofibrate orally once daily, immediately after a meal. ○ Older adults: Dose reduction is generally not necessary if renal function is not impaired. ○ Patients with renal impairment: Do not administer this medicine to patients with moderate to severe renal impairment (serum creatinine level of 2.5 mg/dL or greater).

Child dose

○ Children: Clinical data on the use of this medicine in children are not yet available.

Precautions

This medication should not be used in patients with impaired liver function. Patients with moderate to severe renal impairment should also not receive this drug, as there is a risk of severe muscle damage. Women who are pregnant or may become pregnant, and nursing mothers should not take this medication. Patients with allergies to this drug or its ingredients should avoid taking it. It is also advisable not to administer this drug to patients with gallbladder problems or a history of gallstones. Patients who have previously shown hypersensitivity to sunlight while taking fibrates or ketoprofen, children, patients with biliary issues, and those with pancreatitis should not use this medication. Additionally, this drug contains lactose, so patients with certain genetic lactose intolerance should avoid it, and patients with allergies to soybean oil, soy, or peanuts should exercise caution. Patients with mild renal impairment or liver dysfunction should use this medication cautiously and may need to reduce the dosage or increase the interval between doses. Patients with hypoalbuminemia, a history of gallstones, those taking anticoagulants, elderly patients, and individuals with lipid metabolism disorders should also be monitored closely. This medication may affect the liver and bile ducts, leading to elevated liver enzymes or conditions such as gallstones or hepatitis; thus, regular liver function testing is required. Skin rashes or itching, and in rare cases, hair loss may occur. Symptoms such as dizziness, headache, myalgia, muscle cramps, or thrombosis may appear, and if any unusual symptoms occur, seek medical advice immediately. Gastrointestinal disturbances such as abdominal pain, nausea, vomiting, and diarrhea may occur, and pancreatitis may develop rarely. This medication may alter blood test values, so regular blood tests are recommended. If symptoms such as myalgia, weakness, or elevated creatine kinase levels occur, discontinue the medication and consult a doctor. Interactions may occur when this drug is taken with other specific medications, especially anticoagulants, hypoglycemic agents, and certain cholesterol-lowering drugs; therefore, consult a healthcare professional before concurrent use. This drug should not be taken during pregnancy as it may harm the fetus, and it is also advisable to avoid taking it while nursing. It should not be used in children, and in elderly patients, if renal function is impaired, precaution is especially necessary. There is no specific antidote for overdose, so dosages should be strictly followed, and it should be kept out of reach of children. Transferring this medication to another container is not advisable as it may adversely affect quality.

Side effects

  • Elevation of serum amino transferases
  • liver enlargement
  • cholestatic hepatitis
  • gallstones
  • rash
  • itching
  • photosensitivity reaction
  • alopecia
  • malaise
  • fever
Show 43 more
  • dizziness
  • headache
  • peripheral neuropathy
  • thrombosis
  • elevation of creatine kinase
  • myalgia
  • muscle cramps
  • arthralgia
  • rhabdomyolysis
  • urticaria
  • photoallergic dermatitis
  • gastrointestinal disturbances
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • abdominal distension
  • pancreatitis
  • seizure disorders
  • decrease in hemoglobin
  • leukopenia
  • eosinophilia
  • elevation of serum creatinine
  • eosinophilic pneumonia
  • ventricular arrhythmia
  • fatigue
  • sexual dysfunction
  • weight gain
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • skin rash
  • anaphylaxis
  • angioedema
  • DRESS syndrome
  • exfoliative dermatitis
  • fever
  • systemic organ involvement
  • thrombocytopenia
  • agranulocytosis
  • myopathy
  • pulmonary embolism
  • deep vein thrombosis
  • elevation of serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. Also, it is advisable to store the medication at room temperature between 1°C and 30°C, avoiding extreme heat or cold.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

100 tablets (10 tablets/PTP packaging x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.